Incretin-Based Metabolic Therapies in Cardiovascular Medicine A Comprehensive Review of Clinical Outcomes, Pathophysiological Mechanisms, and Future Frontiers Index Terms atherosclerosis, cardiometabolic medicine, cardiorenal protection, cardiovascular outcomes trials, dipeptidyl peptidase-4 inhibitors, dual GIP/GLP-1 receptor agonist, glucagon-like peptide-1 receptor agonist, heart failure with preserved ejection fraction, plaque stabilization, semaglutide, tirzepatide, type 2 diabetes
J.VilstrupH.GeorgeJ.et al (2019)
Expectation-setting matters
Tiredness is typically most noticeable during dose escalation and may temporarily worsen with each dose increase
With arguably the best CoolSculpting Atlanta has to offer, patients may return to normal daily activities immediately, with no restrictions